Biomarker for the Prediction of Major Adverse Cardiac Events in Patients with Non-ST-Segment Elevation Myocardial Infarction

Figure 1. MACEs that occurred during the 12-month follow-up period after PCI. NSTEMI, non-ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction; MACE, major adverse cardiac event; MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting.

Figure 2. Receiver operating characteristic curve of myocardial infarction in terms of N-terminal pro-brain natriuretic peptide (NT-proBNP).

Figure 3. Receiver operating characteristic curve of repeat percutaneous coronary intervention in terms of N-terminal pro-brain natriuretic peptide (NT-proBNP).

Figure 4. Receiver operating characteristic curve of cardiac death in terms of N-terminal pro-brain natriuretic peptide (NT-proBNP).

Figure 5. Receiver operating characteristic curve of coronary artery bypass grafting in terms of N-terminal pro-brain natriuretic peptide (NT-proBNP).